NCT02214992View on ClinicalTrials.gov

Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2007

Conditions
Healthy
Interventions
DRUG

Telmisartan/Ramipril

Fixed dose combination tablet

DRUG

Telmisartan

DRUG

Ramipril capsule

DRUG

Ramipril tablet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02214992 - Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter